STADA Arzneimittel AG Logo

STADA Arzneimittel AG

A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.

SAZ | HM

Overview

Corporate Details

ISIN(s):
DE0007251803 (+1 more)
LEI:
529900FMTTLMH0P0DL10
Country:
Germany
Address:
Stadastraße 2 - 18, 61118 Bad Vilbel
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

STADA Arzneimittel AG is a global pharmaceutical company operating with a three-pillar strategy consisting of Generics, Consumer Healthcare, and Specialty Pharmaceuticals. The company is a leading European player in its core segments, ranking as the fourth-largest manufacturer of both generics and consumer healthcare products. Its Generics division focuses on providing affordable medicines. The Consumer Healthcare business is driven by a portfolio of strong regional and 'Local Hero' brands. The Specialty Pharmaceuticals segment develops and markets innovative treatments for specific conditions, including biologic therapies. With a heritage rooted in pharmacies and dating back to 1895, STADA's purpose is to be a trusted partner in caring for people's health.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for STADA Arzneimittel AG and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB

Automate Your Workflow. Get a real-time feed of all STADA Arzneimittel AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for STADA Arzneimittel AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Onesano S.A. Logo
Develops patented nutritional products for humans, animals, and agriculture.
Poland SKT
ONO PHARMACEUTICAL CO., LTD. Logo
Develops innovative medicines for high unmet needs in oncology, immunology, and neurology.
Japan 4528
OPKO Health Inc. Logo
Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.
Israel OPK
Oramed Pharmaceuticals Inc. Logo
Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.
Israel ORMP
Orexo Logo
Develops pharmaceuticals & digital health for opioid use disorder in the US market.
Sweden ORX
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF

Talk to a Data Expert

Have a question? We'll get back to you promptly.